Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimen

Clinical trial NCT05028322 · UNKNOWN

Trial details

NCT number: NCT05028322
Sponsor: Central Hospital, Nancy, France
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cirrhosis, Liver Vaccination Failure HBV Vaccine Reaction

Start date: 2021-11-01
Primary completion: 2024-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.